• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偏头痛病史:IV-tPA 治疗的卒中样发作模拟物中弥散加权成像呈阴性的预测因素。

Migraine History: A Predictor of Negative Diffusion-Weighted Imaging in IV-tPA-Treated Stroke Mimics.

机构信息

Ayer Neuroscience Institute, Hartford HealthCare, Hartford Hospital, Hartford, Connecticut; University of Connecticut, Hartford, Connecticut.

Ayer Neuroscience Institute, Hartford HealthCare, Hartford Hospital, Hartford, Connecticut; University of Connecticut, Hartford, Connecticut.

出版信息

J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104282. doi: 10.1016/j.jstrokecerebrovasdis.2019.06.040. Epub 2019 Aug 8.

DOI:10.1016/j.jstrokecerebrovasdis.2019.06.040
PMID:31401044
Abstract

BACKGROUND

Migraine, seizures, and psychiatric disorders are frequently reported as "stroke mimics" in patients with negative diffusion-weighted imaging (DWI) after IV-tPA. We sought to determine predictors of negative DWI in suspected stroke patients treated with IV-tPA.

METHOD

A retrospective case-control study encompassing all acute stroke patients treated with IV-tPA (at our hospital or "dripped and shipped") from January 2013 to December 2014 was con- ducted. A total of 275 patients were identified with 47 negative DWI cases and 228 positive DWI controls. Variables including demographic factors, stroke characteristics, and clinical comorbidities were analyzed for statistical significance. A multivariate logistic regression was performed (SPSS-24) to identify predictors of negative DWI.

RESULTS

Approximately 17% of patients had negative DWI after IV-tPA. Compared to controls, migraine history independently predicted negative DWI (odds ratio [OR] 5.0 95% confidence interval [CI] 1.03-24.6, P = .046). Increasing age (OR .97 95% CI .94-.99, P = .02) and atrial fibrillation (OR .25 95% CI .08-.77, P = .01) predicted lower probability of negative DWI. Gender, admission NIHSS, treatment location, preadmission modified Rankin scale, diabetes mellitus, hypertension, hyperlipidemia, symptom side, seizure history, and psychiatric history did not predict negative DWI status.

CONCLUSIONS

In our study, roughly 1 in 6 patients treated with IV-tPA were later found to be stroke mimics with negative DWI. Despite a high proportion of suspected stroke mimics in our study, only preexisting migraine history independently predicted negative DWI status after IV-tPA treatment in suspected stroke patients.

摘要

背景

在接受 IV-tPA 治疗后扩散加权成像(DWI)阴性的疑似中风患者中,常报告偏头痛、癫痫发作和精神障碍为“中风模拟症”。我们旨在确定接受 IV-tPA 治疗的疑似中风患者中 DWI 阴性的预测因素。

方法

对 2013 年 1 月至 2014 年 12 月期间在我院或“输液和转运”接受 IV-tPA 治疗的所有急性中风患者进行回顾性病例对照研究。共确定 275 例患者,其中 47 例 DWI 阴性病例和 228 例 DWI 阳性对照。分析了包括人口统计学因素、中风特征和临床合并症在内的变量,以确定统计学意义。采用多变量逻辑回归(SPSS-24)确定 DWI 阴性的预测因素。

结果

约 17%的患者在接受 IV-tPA 后 DWI 呈阴性。与对照组相比,偏头痛病史独立预测 DWI 阴性(优势比 [OR] 5.0,95%置信区间 [CI] 1.03-24.6,P=0.046)。年龄增加(OR 0.97,95%CI 0.94-0.99,P=0.02)和心房颤动(OR 0.25,95%CI 0.08-0.77,P=0.01)预测 DWI 阴性的可能性较低。性别、入院 NIHSS、治疗地点、入院前改良 Rankin 量表、糖尿病、高血压、高脂血症、症状侧、癫痫发作史和精神病史均不能预测 DWI 阴性状态。

结论

在我们的研究中,接受 IV-tPA 治疗的患者中约有 1/6 被发现为 DWI 阴性的中风模拟症。尽管我们的研究中有相当高比例的疑似中风模拟症,但只有预先存在的偏头痛病史独立预测了疑似中风患者接受 IV-tPA 治疗后的 DWI 阴性状态。

相似文献

1
Migraine History: A Predictor of Negative Diffusion-Weighted Imaging in IV-tPA-Treated Stroke Mimics.偏头痛病史:IV-tPA 治疗的卒中样发作模拟物中弥散加权成像呈阴性的预测因素。
J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104282. doi: 10.1016/j.jstrokecerebrovasdis.2019.06.040. Epub 2019 Aug 8.
2
Intravenous Tissue Plasminogen Activator in Stroke Mimics.静脉注射组织型纤溶酶原激活剂治疗疑似中风患者
Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005609. doi: 10.1161/CIRCOUTCOMES.119.005609. Epub 2019 Aug 15.
3
Clinical Predictors of Stroke Mimics in Patients Treated with Recombinant Tissue Plasminogen Activator according to a Normal Multimodal Computed Tomography Imaging.根据正常多模态计算机断层扫描成像,接受重组组织型纤溶酶原激活剂治疗的患者中类似中风的临床预测因素。
J Stroke Cerebrovasc Dis. 2018 Feb;27(2):454-459. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.024. Epub 2017 Nov 8.
4
Critical Care Needs in Patients with Diffusion-Weighted Imaging Negative MRI after tPA--Does One Size Fit All?组织型纤溶酶原激活剂治疗后磁共振成像扩散加权像阴性患者的重症监护需求——一种方案适用于所有情况吗?
PLoS One. 2015 Oct 30;10(10):e0141204. doi: 10.1371/journal.pone.0141204. eCollection 2015.
5
Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective.在 MRI DWI/T2WI 不匹配的指导下,对发病超过 4.5 小时的缺血性中风患者进行静脉 tPA 治疗是安全有效的。
Stroke Vasc Neurol. 2019 Feb 11;4(1):8-13. doi: 10.1136/svn-2018-000186. eCollection 2019 Mar.
6
Negative diffusion-weighted imaging after intravenous tissue-type plasminogen activator is rare and unlikely to indicate averted infarction.静脉注射组织型纤溶酶原激活物后出现弥散受限为阴性的情况很少见,且不太可能表明梗死被逆转。
Stroke. 2013 Jun;44(6):1629-34. doi: 10.1161/STROKEAHA.111.000486. Epub 2013 Apr 9.
7
Presence of deep white matter lesions on diffusion-weighted imaging is a negative predictor of early dramatic improvement after intravenous tissue plasminogen activator thrombolysis.弥散加权成像上存在深部白质病变是静脉注射组织型纤溶酶原激活物溶栓后早期显著改善的负预测因子。
Cerebrovasc Dis. 2010 Aug;30(3):230-6. doi: 10.1159/000317183. Epub 2010 Jul 1.
8
Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.治疗前弥散加权成像病灶体积可预测急性缺血性脑卒中患者接受组织型纤溶酶原激活物静脉溶栓后的良好结局。
Stroke. 2011 May;42(5):1251-4. doi: 10.1161/STROKEAHA.110.600148. Epub 2011 Mar 17.
9
Intravenous Thrombolysis Increases the Rate of Dramatic Recovery in Patients with Acute Stroke with an Unknown Onset Time and Negative FLAIR MRI.静脉溶栓可提高急性起病时间不明且FLAIR MRI阴性的急性卒中患者显著恢复的比例。
J Neuroimaging. 2016 Jul;26(4):414-9. doi: 10.1111/jon.12323. Epub 2015 Dec 21.
10
Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.静脉注射重组组织型纤溶酶原激活剂后出血转化的预测因素:初始表观扩散系数和扩散加权病变体积的预后价值
Stroke. 2002 Aug;33(8):2047-52. doi: 10.1161/01.str.0000023577.65990.4e.

引用本文的文献

1
Intravenous tissue plasminogen activator in functional stroke mimics.静脉注射组织型纤溶酶原激活剂用于功能性卒中模拟症
Postep Psychiatr Neurol. 2025 Mar;34(1):33-43. doi: 10.5114/ppn.2025.149942. Epub 2025 Apr 30.
2
Neuroimaging for differential diagnosis of transient neurological attacks.神经影像学在短暂性脑卒中性神经发作鉴别诊断中的应用。
Brain Behav. 2022 Dec;12(12):e2780. doi: 10.1002/brb3.2780. Epub 2022 Nov 9.
3
Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis.
联合表观扩散系数使用扩散加权成像方法鉴别原发性中枢神经系统淋巴瘤和高级别胶质瘤的诊断准确性:系统评价与Meta分析
Front Neurol. 2022 Jun 24;13:882334. doi: 10.3389/fneur.2022.882334. eCollection 2022.
4
Stroke mimics: incidence, aetiology, clinical features and treatment.脑卒中类似疾病:发病率、病因、临床特征及治疗。
Ann Med. 2021 Dec;53(1):420-436. doi: 10.1080/07853890.2021.1890205.